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Lúcia Fernandes, MD, and José A. Pereira, MDABSTRACT
In 9 of 491 patients (1.8%) who underwent prostatic arterial embolization (PAE) for benign prostatic hyperplasia from March
2009–November 2013, prostatic arteries arose from the external iliac artery via an accessory obturator artery (AOA). Computed
tomography angiography performed before the procedure identiﬁed the variant and allowed planning before the procedure. The
nine AOAs were catheterized from a contralateral femoral approach. Bilateral PAE was technically successful in the nine
patients. There was a mean decrease in international prostate symptom score of 6.5 points and a mean prostate volume
reduction of 15.1% (mean follow-up, 4.8 mo) in the nine patients.
ABBREVIATIONS
AOA = accessory obturator artery, DSA = digital subtraction angiography, IPSS = International Prostate Symptom Score,
PAE = prostatic arterial embolization, PVA = polyvinyl alcohol, QoL = quality of lifeProstatic arterial embolization (PAE) to relieve lower
urinary tract symptoms in patients with benign prostatic
hyperplasia is a challenging procedure partly because of
the highly variable origin and complex anatomy of the
prostatic arteries (1). Computed tomography (CT)
angiography performed before PAE has been used to
help identify the prostatic arteries and to guide the
procedure (2). The prostatic arteries may arise from
the different branches of the internal iliac artery,
including from the obturator artery, in 13% of pelvic
sides (1,2). However, the obturator artery may arise
from the inferior epigastric artery or directly from the
external iliac artery and be named an accessory or& SIR, 2014
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variation that may be present in 30% of pelvic sides (3).
Prostatic arteries arising from AOAs are a possible
variant of particular relevance when performing PAE.
The purpose of this report is to clarify this anatomic
variation and report successful catheterization and
embolization in nine patients with lower urinary tract
symptoms related to benign prostatic hyperplasia.MATERIALS AND METHODS
The institutional review board waived the need to obtain
permission to perform this retrospective analysis. From
March 2009–November 2013, PAE was performed in
491 patients to relieve lower urinary tract symptoms
secondary to benign prostatic hyperplasia. Nine patients
with prostatic arteries arising from AOAs were included.
AOAs were classiﬁed as (i) obturators arising from the
inferior epigastric artery, (ii) obturators arising directly
from the external iliac artery, or (iii) codominant
obturators originating from both the external and the
internal iliac artery systems (3).
Among the nine patients evaluated, mean patient age
was 62.9 years (range, 51–74 y). Mean International
Prostate Symptom Score (IPSS) was 18.9 points (range,
14–21 points), mean quality of life (QoL) score was
4.0 points (range, 3–6 points). Mean peak ﬂow rate was
11.2 mL/s (range, 5.9–13.5 mL/s), mean postvoid residual
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speciﬁc antigen level was 4.2 ng/mL (range, 0.6–10.7 ng/
mL), and mean prostate volume was 78.9 cm3 (range,
52–155 cm3). None of the patients were experiencing
acute urinary retention before PAE.
All patients underwent CT angiography before PAE as
previously described (1). PAE was performed under local
anesthesia by a contralateral femoral approach; when the
prostatic artery originated from the right AOA, the left
femoral artery was punctured and vice versa. A Roberts
uterine catheter (Cook, Inc, Bloomington, Indiana) was
used in every patient to catheterize the inferior epigastric
artery.
Digital subtraction angiography (DSA) of the inferior
epigastric artery was performed in a contralateral ante-
rior oblique projection (25 degrees). The AOA and
prostatic artery were identiﬁed with CT angiography
and DSA and catheterized with 2.4-F to 2.7-F
microcatheters (Cantata; Cook, Inc; Progreat; Terumo,
Tokyo, Japan) and 0.016-inch guide wires (Sagitta-16
Wire Guide; Cook, Inc; Glidewire GT; Terumo). Selec-
tive DSA of the prostatic artery (4–5 mL; at 2 mL/s)
in neutral and contralateral anterior oblique (25
degrees) projections was performed before and after
embolization.
Bilateral PAE was performed with 100-μm polyvinyl
alcohol (PVA) particles (Cook, Inc) (n ¼ 1 patient), 100-
μm and 200-μm PVA particles (n ¼ 4 patients), 200-μm
PVA particles (n ¼ 1 patient), 300- to 500-μm tris-acryl
microspheres (Embosphere; BioSphere Medical, Rock-
land, Massachusetts) (n ¼ 1 patient), 300- to 500-μm
spherical PVA particles (Bead Block; Terumo) (n ¼ 1
patient), and 400-μm Polyzene-coated microspheres
(Embozene; CeloNova BioSciences, Inc, Peachtree City,
Georgia) (n ¼ 1 patient). The endpoint of embolization
was occlusion of the identiﬁable vessels supplying the
prostate and reﬂux toward the prostatic artery origin or
into the epigastric artery.
Patients were evaluated before and 1, 3, 6, and 12
months after PAE with IPSS and QoL questionnaires,
ﬂuxometry, prostate-speciﬁc antigen, and prostate vol-
ume with transrectal ultrasound (4).RESULTS
During the study time period, 9 of 491 patients (1.8%)
had prostatic arteries arising from an AOA. There was
no case of prostatic arteries arising from an AOA on
both pelvic sides. In seven patients, the prostatic artery
arose from an AOA on the left pelvic side, and in 2
patients, the prostatic artery arose from an AOA on the
right pelvic side. In seven patients, the AOA arose from
the inferior epigastric artery (78%), and in 2 patients, the
AOA arose directly from the external iliac artery (22%).
There were no patients with codominant AOAs from
both internal and external iliac artery systems. Theprostatic artery origin from the AOA was identiﬁed with
CT angiography before PAE and conﬁrmed during the
procedure in all 9 patients (Fig 1a–d).
The prostatic artery arising from the AOA was the
central gland or anterolateral prostatic artery in all
patients (Fig 2a–d, Video 1 [available online at www.
jvir.org]) (1). In four patients, this was the single
prostatic artery from that pelvic side, whereas in the
remaining ﬁve patients, a posterolateral or caudal
prostatic artery was identiﬁed arising from the internal
iliac artery system (internal pudendal artery in three
patients; inferior gluteal artery in two patients) (1).
Mean procedural time was 83.3 minutes (range, 50–
120 min), and mean ﬂuoroscopy time was 28.0 minutes
(range, 12.4–59.8 min). All patients were able to void
spontaneously after PAE. No severe pain was reported
during or after PAE. One patient reported slight self-
limited hematuria in the ﬁrst 3 days after PAE. There
were no other major or minor adverse events according
to the Society of Interventional Radiology (SIR) cri-
teria (5).
Mean follow-up time was 4.8 months (range, 1–12
mo): 1 month in one patient; 3 months in four patients; 6
months in three patients, and 12 months in one patient.
There was a mean decrease in IPSS of 6.5 points and in
QoL severity score of 2 points. After PAE, the mean
IPSS/QoL severity score was 12.4/2 points. Mean pros-
tate volume reduction was 11.9 cm3 (15.1%), mean
prostate-speciﬁc antigen reduction was 1.0 ng/mL
(23.8%), mean peak ﬂow rate increase was 2.8 mL/s
(25%), and mean postvoid residual urine reduction was
84.7 mL (78.4%).DISCUSSION
This work highlights the need to look for an AOA when
performing PAE, especially when no prostatic arteries
are identiﬁed inside the pelvis arising from the internal
iliac artery branches. AOAs are familiar to most
interventional radiologists, and they should be looked
for after pelvic trauma because they may be the source
of bleeding (6). AOAs have also been given the name of
“corona mortis”; however, there is no consensus on the
deﬁnition of the corona mortis. Some authors consider
the corona mortis to be limited to AOAs, whereas
others consider it to be any venous or arterial
communication between the external and internal iliac
systems through the obturator vessels (3,6). In this
study, AOAs were deﬁned as any obturator artery
arising from the inferior epigastric artery (78%) or
directly from the external iliac artery (22%) (3,6). None
of the reported patients had codominant or anasto-
motic obturator arteries from both internal and exter-
nal iliac artery systems.
Cadaveric and imaging studies have described in detail
the prostatic artery anatomy relevant for embolization
Figure 1. Single prostatic artery (solid arrow) arising from an AOA (dashed arrows) directly from the external iliac artery on the right
pelvic side. (a) CT angiography volume rendering reformat. (b) CT angiography axial minimum intensity projection reformat. (c) CT
angiography coronal curved minimum intensity projection reformat. (d) Selective DSA of the right AOA in neutral position. Note the
Roberts uterine catheter (arrowhead) through a contralateral femoral approach.
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from the branches of the internal iliac artery. The rare
incidence of prostatic arteries arising from AOAs (o 2%
from our experience) may explain why it was not
reported before. Previous studies on prostatic artery
anatomy included o 75 patients (1,2,7,8), which was
probably the reason for not reporting this variant.
This study also reinforces the role of imaging planning
for PAE before the procedure. The presence of prostatic
arteries arising from AOAs outside the pelvis could lead
to an increase in procedural and ﬂuoroscopy times or to
unilateral embolization procedures. However, the meanprocedural and ﬂuoroscopy times were comparable to
previously reported results (4), and bilateral PAE was
achieved in every patient; we believe this to be due to the
use of CT angiography before PAE.
The contralateral femoral artery was punctured to
facilitate catheterization of the AOA. Ipsilateral femoral
puncture could have led to failed catheterization of the
AOA. Through contralateral femoral access, all inferior
epigastric arteries were catheterized with a Roberts
uterine catheter. Contrary to the standard ipsilateral
oblique view used in the pelvis during internal iliac
artery DSA before PAE (1), the contralateral anterior
Figure 2. Prostatic artery (solid arrows) arising from an AOA (dashed arrows) from the inferior epigastric artery (arrowhead) on the left
pelvic side. (a) Selective DSA of the left inferior epigastric artery in neutral position. (b) Selective DSA of the left inferior epigastric artery
in contralateral anterior oblique (25 degrees) projection. Note the Roberts uterine catheter (large arrows) through a contralateral femoral
approach. The three arteries are easier to depict in this projection. (c) Selective prostatic artery DSA in neutral projection after selective
catheterization with a microcatheter (dashed arrow). (d) Angiogram obtained after embolization.
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depict the inferior epigastric artery, AOA, and prostatic
artery correctly. In this projection, the AOA and pro-
static artery are well depicted, and selective prostatic
artery catheterization becomes easier with the use of a
microcatheter.
Although the number of patients is small, the clinical
results reported are similar to larger series (4). As long as
the prostatic artery is correctly identiﬁed and embolization
is performed correctly, no signiﬁcant complications are
expected—from untargeted embolization to the abdominal
wall, lower limbs, bladder, rectum, or penis.
This study has some limitations. We evaluated only
patients with prostatic arteries arising from AOAs andnot all patients with AOAs. Our goal was to highlight
the possibility of prostatic arteries arising from outside
the pelvis and not to describe AOAs, as previously
reported (3). The retrospective nature of the analysis,
in a small cohort of patients with a short and variable
follow-up time, is an additional limitation to the inter-
pretation of these results. During this study (4-year
duration), we were able to identify only nine patients
with prostatic arteries from AOAs (o 2%). The use of
different embolic agents reﬂects the long time period of
this study.
In conclusion, when performing PAE, interventional-
ists should be aware thato 2% of patients have prostatic
arteries arising from AOAs outside the pelvis. Imaging
Volume 25 ’ Number 6 ’ June ’ 2014 879planning with CT angiography before a procedure
correctly identiﬁes this variant and may help guide PAE.REFERENCES
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